Cellebrite DI Ltd.

NASDAQ:CLBT

Software - Infrastructure

Technology
$10.65 -0.40%

-$0.05 today

Market cap
$2.68B
Beta
1.17
P/E (TTM)
42.6
EPS (TTM)
$0.29
52W Low $11.02High $19.98

Volume 3.48M

Average 2.08M

Big Five Numbers

Cellebrite DI Ltd. growth analysis

Start with the long-run numbers that show whether CLBT compounds: return on capital and growth in sales, earnings, equity, and free cash flow.

Big Five Numbers

CAGR by period · ROIC shows average

Metric 10yr 5yr3yr1yr
EPS
N/AN/A-19.3%N/A
Revenue
N/AN/A+20.7%+18.6%
Equity
N/AN/A+68.6%+20.8%
Cash
N/AN/A+12.4%-35.1%
ROIC
N/A8.8%11.8%10.0%

Analysis

Latest growth is strongest in Equity at +20.8% and weakest in Cash at -35.1%. Three-year average ROIC is 11.8%, which helps show whether that growth is being earned efficiently.

Growth analysis

Is growth accelerating or fading?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/A-19.3%
+30.9% (4yr)1 analysts
RevenueN/AN/A+20.7%
+16.1% (4yr)1 analysts
Net IncomeN/AN/A-13.4%
+30.5% (4yr)1 analysts
EBITN/AN/A+299.3%
+52.2% (4yr)1 analysts

Analysis

Recent growth has been strongest in EBIT at +299.3% over three years. Forward estimates point to EBIT at +52.2% (4yr), giving you a quick check on whether expectations are accelerating or cooling.

Revenue segments

Where does the growth come from?

Break revenue down by product and geography to see which parts of the business drive the trend.

Revenue by segment

Where CLBT earns its revenue, as reported in company filings

  • Subscription Services
  • Term-Licenses
  • Professional Services
  • License and Service
  • Perpetual Licenses And Other
Revenue by segment for FY2025
Segment · FY2025 Revenue Share YoY
Subscription Services$330.77M72.2%+22.0%
Term-Licenses$96.25M21.0%+17.4%
Professional Services$30.89M6.7%+0.0%

Figures in USD. Segments account for 96.3% of reported FY2025 revenue; $17.77M is not attributed to a segment.

Free cash flow

Does growth turn into cash?

Check whether reported growth converts into free cash flow after capital spending.

Free Cash Flow

Net Income to FCF bridge

Cash Flow Statement

FY2025

= Net Income$78.3M
+ D&A$11.9M
+ Stock-Based Comp$0
+ Deferred Tax$75.0K
+ Working Capital$42.0M
+ Other Non-Cash$36.7M
= Operating Cash Flow$169.0M
- Capex-$13.2M
= Free Cash Flow$155.7M

Analysis

FY2025 free cash flow is $155.7M. FCF conversion is 198.8% of net income. Operating cash flow was $169.0M, with capex of -$13.2M. The largest bridge item is Working Capital at $42.0M.

Price targets

What do analysts expect from the price?

Compare the current price with the low, average, and high analyst targets.

Wall Street price targets

1-year price history with analyst consensus target

Growth

Unlock analyst target range

Sign in free to see low, average, high targets and implied upside for CLBT.

Sign in free

Analyst ratings

How do analysts rate the stock?

Review the buy, hold, and sell split and recent upgrades and downgrades.

Analyst ratings

Buy, hold, and sell recommendations and recent rating changes

Unlock analyst ratings

Sign in free to see the buy/hold/sell breakdown and recent rating changes for CLBT.

Sign in free

Competitor growth

How does Cellebrite DI Ltd. grow against peers?

Compare historical and forecast growth with similar companies.

Competitor Growth

Peer CAGR comparison & forward estimates

CompanyMarket Cap10yr5yr3yrFwd

Axon Enterprise, Inc.

AXON

$25.69B+30.2%+32.5%+32.7%
+27.9% (3yr)14 analysts

SoundThinking, Inc.

SSTI

$109.37M+24.3%+17.9%+8.7%
+6.3% (3yr)1 analysts

SuperCom Ltd.

SPCB

$38.75M-0.6%+18.8%+16.5%
+13.0% (3yr)1 analysts

Questions

Growth questions

Common questions about CLBT's growth, answered from reported and forecast figures.

Is CLBT growing revenue?

Revenue grew 18.6% year over year, from $401.20M to $475.68M.

Is CLBT turning growth into profit?

The latest net margin is 16.5%, which shows how much revenue became net income.